Innovation
DETERA Therapeutics, a peptide to prevent crescentic glomerulonephritis (CGN)
… of Medicines and Health Technologies (MTS - Univ. Paris-Saclay/INRAE/CEA) . These are Daniel Gillet, research … also very complementary: when the three of us met at SATT Paris-Saclay, Daniel Gillet and Pierre-Louis Tharaux had … of Medicines and Health Technologies (MTS - Univ. Paris-Saclay/INRAE/CEA) . These are Daniel Gillet, research …
Published on: